OTC · Drug Manufacturers - Specialty & Generic

Mountain Valley MD Holdings Inc. (MVMDF) Stock

$0.06 -0.60% OTC: MVMDF Healthcare

Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., is a company focused on the health and wellness industry. The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors.

Valuation

MetricValue
Price$0.06
Market Cap$19.70M
P/E Ratio-9.37
P/B Ratio-187.42
P/S Ratio406.56
EPS (TTM)$-0.01
52-Week High$0.09
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-314.49%
ROA-533.40%
ROCE-890.84%
Gross Margin56.92%
Operating Margin-2446.15%
Net Margin0.00%
Debt/Equity-2.86
Current Ratio1.71

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-9.0M$-5.0M$-3.0M$-3.0M$-2.0M
Net Profit$-10.0M$-7.0M$-8.0M$-7.0M$-3.0M
EPS$-0.03$-0.02$-0.02$-0.02$-0.01
Op Margin-8446.4%—-5326.7%-6922.4%-3590.9%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$25.0M$17.0M$9.0M$3.0M$1.0M
Total Liabilities$0$1.0M$0$0$1.0M
Cash$14.0M$10.0M$6.0M$2.0M$0
Borrowings$0$0$0$0$0

Latest News

The More Life Company Corp. Announces New U.S. Trading Symbol Business Wire · Aug 20, 2026 The More Life Company Corp. Announces Completion of Name Change From Mountain Valley MD Holdings Inc. Business Wire · Aug 18, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-6.0M$-5.0M$-3.0M$-4.0M$-2.0M
Investing Cash Flow$0$2.0M$-1.0M$0$0
Financing Cash Flow$0$-2.0M$0$0$0
Net Cash Flow$-5.0M$-5.0M$-4.0M$-4.0M$-1.0M
Free Cash Flow$-6.0M$-5.0M$-4.0M$-4.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.13
EV / EBITDA-11.75
FCF Yield-7.62%
Quick Ratio1.71
Interest Coverage0.00
Return 1Y287.86%
Return 3Y71.10%
Return 5Y—

Ownership

Insiders Held0.90%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Game Plan Financial Advisors, Llc1,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BNXT.CNBioNxt Solutions Inc. $0.33 -13.16% -4.86 $47.63M 0.00%
DOSE.CNRapid Dose Therapeutics Corp. $0.10 +0.00% -6.00 $16.22M 0.00%
GLOW.CNGlow Lifetech Corp. $0.04 +0.00% — $8.66M 0.00%
INNO.CNInnoCan Pharma Corporation $1.95 -11.36% -4.89 $9.00M 0.00%
LABS.TOMediPharm Labs Corp. $0.07 +0.00% -8.00 $32.04M 0.00%

About Mountain Valley MD Holdings Inc.

Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., is a company focused on the health and wellness industry. The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors. Its portfolio includes Quicksome, an advanced oral drug formulation and delivery system; Quicksol, a technology designed to improve solubility; and a dose-sparing adjuvant. Currently, the company is also progressing with the development of IM032, a treatment being tested in male beagle dogs to assess the differences between intramuscular and subcutaneous administration routes. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.

Mountain Valley MD Holdings Inc. is headquartered in CA.

Mountain Valley MD Holdings Inc. (MVMDF) stock trades at $0.06 with a market capitalization of $19.70M. The stock is valued at a price-to-earnings (P/E) ratio of -9.37, price-to-book of -187.42, price-to-sales of 406.56. Over the past 52 weeks the stock has ranged between $0.01 and $0.09, and currently trades 33.3% below its 52-week high.

On profitability, Mountain Valley MD Holdings Inc. generates a return on equity (ROE) of -314.49%, return on capital employed of -890.84%, an operating margin of -2446.15%, a net profit margin of 0.00%.

Official website: www.mvmd.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides